Showing 1–4 of 4 results
-
Research |
Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial
- Jeremy St John Thomas
- , Elena Provenzano
- , Louise Hiller
- , Janet Dunn
- , Clare Blenkinsop
- , Louise Grybowicz
- , Anne-Laure Vallier
- , Ioannis Gounaris
- , Jean Abraham
- , Luke Hughes-Davies
- , Karen McAdam
- , Stephen Chan
- , Rizvana Ahmad
- , Tamas Hickish
- , Stephen Houston
- , Daniel Rea
- , Carlos Caldas
- , John MS Bartlett
- , David Allan Cameron
- , Richard Laurence Hayward
- & Helena Margaret Earl
-
Amendments and Corrections | | Open
Erratum: Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer
- Yvette Drew
- , Jonathan Ledermann
- , Geoff Hall
- , Daniel Rea
- , Ros Glasspool
- , Martin Highley
- , Gordon Jayson
- , Julieann Sludden
- , James Murray
- , David Jamieson
- , Sarah Halford
- , Gary Acton
- , Zoe Backholer
- , Raffaella Mangano
- , Alan Boddy
- , Nicola Curtin
- & Ruth Plummer
British Journal of Cancer 114 , e21–e21 -
Research | | Open
-
| Open
Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer
- Yvette Drew
- , Jonathan Ledermann
- , Geoff Hall
- , Daniel Rea
- , Ros Glasspool
- , Martin Highley
- , Gordon Jayson
- , Julieann Sludden
- , James Murray
- , David Jamieson
- , Sarah Halford
- , Gary Acton
- , Zoe Backholer
- , Raffaella Mangano
- , Alan Boddy
- , Nicola Curtin
- & Ruth Plummer
British Journal of Cancer 114 , 723–730
